Cargando…
Cystic fibrosis transmembrane regulator correction attenuates heart failure-induced lung inflammation
Heart failure (HF) affects 64 million people worldwide. Despite advancements in prevention and therapy, quality of life remains poor for many HF patients due to associated target organ damage. Pulmonary manifestations of HF are well-established. However, difficulties in the treatment of HF patients...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365932/ https://www.ncbi.nlm.nih.gov/pubmed/35967318 http://dx.doi.org/10.3389/fimmu.2022.928300 |